Summary
Patients requiring device implantation need lifelong care. However, with appropriate selection of the device and appropriate follow-up, lifestyle changes attributed to the device can be minimized. Exercise limitations, beyond those needed to protect the device and the overlying skin, are often not necessary beyond those due to the underlying cardiac status. As new technologies are developed that minimize battery drain and increase the time between invasive procedures, device longevity is nowreaching 7 to 10 years. Devices for which longevity data are available are obsolete. Electrode lead longevity, however, can more accurately be estimated. In our experience, electrode lead longevity is between 10 to 12 years for transvenous leads and 5 to 8 years for epicardial ones.
The goal of all pacemaker management is to improve cardiac performance and to permit the patient to lead an active and normal lifestyle. As newer indications for device use emerge, the number of patients requiring device implantation will increase making attainment of this goal increasingly important.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Suggested Reading
Serwer GA, Dorostkar PC, LeRoy SS. Pediatric pacing and defibrillator usage. In Clinical Cardiac Pacing and Defibrillation. Ellenbogen KA, Kay GN, Wilkoff BL, eds. W.B. Saunders: Philadelphia, PA 2000.
Gregoratos G, Abrams J, Epstein AE, et al. Guideline update for implantation of pacemakers and antiarrhythmic devices: summary article. Circulation 2002;106:2145–2161.
Weindling SN, Saul JP, Gamble WJ, et al. Duration of complete atrioventricular block after congenital heart disease surgery. Am J Cardiol 1998;82:525–527.
Rishi F, Hulse JE, Auld DO, et al. Effects of dual—chamber pacing for pediatric patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1997;29:734–740.
Stephanson EA, Casavant D, Tuzi J, et al. on behalf of the ATTEST investigators. Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease. Am J Cardiol 2003;92:871–876.
Kristensen L, Nielsen JC, Pedersen AK, et al. AV block and changes in pacing mode during longterm follow-up of 399 consecutive patients with sick sinus syndrome treated with an AAI/AAIR pacemaker. PACE 2001;24:358–365.
Cohen MI, Bush DM, Vetter VL, et al. Permanent epicardial pacing in pediatric patients. Circulation 2001;103: 2585–2590.
Bauersfeld U, Schonbeck M, Candinas R, et al. Initial experiences with a new steroid-eluting bipolar epicardial pacing lead. Eur J Card Pacing Electro 1996;6:222.
Serwer GA, Mericle JM, Armstrong BE. Epicardial ventricular pacemaker electrode longevity in children. Am J Cardiol 1988;61:104–106.
Serwer GA, Uzark K, Dick M II. Endocardial pacing electrode longevity in children. J Am Coll Cardiol 1990;15:212A.
Cohen MI, Buck K, Tanel RE, et al. Capture management efficacy in children and young adults with endocardial and unipolar epicardial systems. Europace 2004;6:248–255.
Johns JA, Fuh FA, Burger JD, Hammon JW Jr. Steroid-eluting epicardial pacing leads in pediatric patients: Encouraging early results. J Am Coll Cardiol 1992;20:395–401.
Karpawich PP, Horenstein MS, Webster P. Site specific right ventricular implant pacing to optimize paced left ventricular function in the young without and without congenital heart disease. PACE 2002;25:566.
Stefanelli CB, Bradley DJ, Leroy S, et al. Implantable cardioverter defibrillator therapy for life-threatening arrhythmias in young patients. J Interven Card Electro 2002;6:235–244.
Fischbach PS, Law IH, Dick M II, et al. Use of a single coil transvenous electrode with an abdominally placed implantable cardioverter defibrillator in children. PACE 2000;23:884.
Strieper M, Karpawich P, Frias P, et al. Initial experience with cardiac resynchronization therapy for ventricular dysfunction in young patients with surgically operated congenital heart disease. AmJ Cardiol 2004;94:1352–1354.
Lee JC, Shannon K, Boyle NG, et al. Evaluation of safety and efficacy of pacemaker and defibrillator implantation by axillary incision in pediatric patients. Pacing Clin Electrophysiol 2004;27(3):304–307.
Blom NA, et al. Transvenous biventricular pacing in a child after congenital heart surgery as an alternative therapy for congestive heart failure. J Cardiovascul Electrophysiol 2003;14(10):1110–1112.
Janousek J, et al. Resynchronization pacing is a useful adjunct to the management of acute heart failure after surgery for congenital heart defects. Am J Cardiol 2001;88(2):145–152.
Zimmerman FJ, et al. Acute hemodynamic bene-fit of multisite ventricular pacing after congenital heart surgery. Ann Thorac Surg 2003;75(6):1775–1780.
Walker F, et al. Long-term outcomes of cardiac pacing in adults with congenital heart disease. J Am Coll Cardiol 2004;43(10):1894–1901.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Serwer, G.A., Law, I.H. (2006). Cardiac Pacemakers and Implantable Cardioverter-Defibrillators. In: Dick, M. (eds) Clinical Cardiac Electrophysiology in the Young. Developments in Cardiovascular Medicine, vol 257. Springer, Boston, MA. https://doi.org/10.1007/0-387-29170-9_17
Download citation
DOI: https://doi.org/10.1007/0-387-29170-9_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-29164-2
Online ISBN: 978-0-387-29170-3
eBook Packages: MedicineMedicine (R0)